Chronic hyperglycemia brought on by insulin resistance and relative insulin insufficiency is a hallmark of type 2 diabetes mellitus (T2DM), a multifactorial metabolic illness. The increasing frequency, morbidity, and mortality linked to macrovascular and microvascular problems make it a significant worldwide health concern.¹

One important factor in the pathophysiology of type 2 diabetes is oxidative stress, which is characterized as an imbalance between pro-oxidant production and antioxidant defense. Through glucose autoxidation, protein glycation, and mitochondrial dysfunction, hyperglycemia causes an excessive production of reactive oxygen species (ROS).² Lipid peroxidation, protein degradation, and compromised insulin signaling are caused by excessive ROS.³

ROS production is balanced by antioxidant defense mechanisms, which include enzymatic antioxidants like glutathione peroxidase (GPx), catalase (CAT), and superoxide dismutase (SOD). T2DM has been linked to decreased activity of these enzymes, which could worsen oxidative damage.⁵ Few research, nevertheless, have thoroughly examined the connection between oxidative stress indicators and glycemic indices in clinical populations.

In this study, 100 T2DM patients' oxidative stress indicators and antioxidant enzyme activities are examined, and their relationship to glycemic control is evaluated.

This cross-sectional observational study was conducted at the Department of Biochemistry, Amaltas Institute of Medical Sciences, Dewas for 01 Year. Written informed consent was obtained from all participants. Inclusion & Exclusion Criteria: Inclusion: Patients aged 30–70 years with a confirmed diagnosis of T2DM (American Diabetes Association criteria).⁶ Exclusion: Patients with Type 1 diabetes, chronic inflammation, acute infections, renal or hepatic dysfunction, antioxidant supplementation, or smokers. Data Collection & Laboratory Measurements Demographic & clinical data (age, sex, duration of diabetes) were recorded. Fasting blood samples were collected for: • Fasting Blood Glucose (FBG) – enzymatic method • HbA1c – high performance liquid chromatography • Malondialdehyde (MDA) – thiobarbituric acid reactive substances (TBARS) assay • Total Antioxidant Capacity (TAC) – spectrophotometric assay • SOD, CAT, GPx activities – standardized spectrophotometric methods.⁷–⁹ Statistical Analysis Data were analyzed using SPSS v23. Continuous variables were expressed as mean ± SD. Group comparisons were performed using t-test & ANOVA. Pearson correlation evaluated associations between oxidative stress markers & glycemic indices. p < 0.05 was considered significant.

The study included 100 T2DM patients: 54 males & 46 females. Mean age was 53.2 ± 9.1 years, & mean duration of diabetes was 7.8 ± 4.3 years.

Table 1. Demographic & Clinical Characteristics of Study Population

Table 2. Oxidative Stress Markers in T2DM Patients

Patients exhibited elevated MDA & reduced TAC compared to standard reference ranges.

Table 3. Antioxidant Enzyme Activities Stratified by HbA1c

Antioxidant enzyme activities were lower in patients with higher HbA1c.

Table 4. Alterations in Oxidative Stress and Antioxidants

The alterations in oxidative stress markers and antioxidant defense systems in patients with Type 2 Diabetes Mellitus, the level of malondialdehyde (MDA), a marker of lipid peroxidation and oxidative stress, was found to be increased, indicating enhanced oxidative damage in diabetic patients. In contrast, the activities of major antioxidant enzymes—superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were observed to be decreased, reflecting an impaired enzymatic antioxidant defense mechanism. Additionally, the level of reduced glutathione (GSH), a key non-enzymatic antioxidant, was also decreased.

This study shows that oxidative stress is linked to poor glycemic control and is markedly elevated in T2DM patients. In line with the results of earlier research, elevated MDA levels indicate increased lipid peroxidation.Reduced antioxidant enzyme activity and TAC indicate a weakened defense against ROS.

Through a number of processes, such as the auto-oxidation of glucose and the generation of superoxide in the mitochondria, hyperglycemia raises oxidative stress.² Protein glycation and cofactor depletion can lead to impaired SOD, CAT, and GPx activity, which exacerbates oxidative damage.Strong positive relationships between MDA and HbA1c suggest that oxidative damage is exacerbated by long-term hyperglycemia. On the other hand, unfavorable associations between glycemic indices and antioxidant enzymes imply that inadequate glycemic control depletes antioxidant defenses. These findings are consistent with previous research on oxidative imbalance in diabetes populations.¹²

Standardized biochemical analyses in a carefully defined patient sample are one of the study's strengths. Its cross-sectional design and absence of a healthy control group are among its drawbacks.

Oxidative stress plays a significant role in T2DM pathogenesis through increased ROS generation & impaired antioxidant defense. Elevated MDA & reduced activities of SOD, CAT, & GPx correlate with worse glycemic control. Therapeutic strategies targeting oxidative stress may help prevent complications in T2DM.

1. American Diabetes Association. Diagnosis & classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81–S90.
2. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625.
3. Rains JL, Jain SK. Oxidative stress, insulin signaling, & diabetes. Free Radic Biol Med. 2011;50(5):567–575.
4. Halliwell B, Gutteridge JMC. Free Radicals in Biology & Medicine. 5th ed. Oxford: Oxford University Press; 2015.
5. Davi G, Ciabattoni G, Consoli A, et al. Platelet activation in obese women: role of inflammation & oxidant stress. JAMA. 2002;288(16):2008–2014.
6. American Diabetes Association. Standards of Medical Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S1–S283.
7. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine & a simple assay for SOD. J Biol Chem. 1972;247(10):3170–3175.
8. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–126.
9. Paglia DE, Valentine WN. Studies on the quantitative & qualitative characterization of erythrocyte GPx. J Lab Clin Med. 1967;70(1):158–169.
10. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40(4):405–412.
11. Giacco F, Brownlee M. Oxidative stress & diabetic complications. Circ Res. 2010;107(9):1058–1070.
12. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, & cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004;24(5):816–823.